Accès gratuit
Numéro
Med Sci (Paris)
Volume 28, Mars 2012
Génomique et recherche clinique en oncologie : approches de sciences humaines, économiques et sociales (SHES)
Page(s) 7 - 13
Section M/S Revues
DOI https://doi.org/10.1051/medsci/2012281s104
Publié en ligne 9 avril 2012
  1. Jones D, Cambrosio A, Mogoutov A. Detection characterization of translational research in cancer, cardiovascular medicine . J Transl Med 2011 ; 9 : 57. [CrossRef] [PubMed]
  2. Chomczynski P, Sacchi N. 1987 Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987 ; 162 : 156–159. [CrossRef] [PubMed]
  3. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning : a laboratory manual. Cold Spring Harbor NY : Cold Spring Harbor Laboratory Press, 1989.
  4. Altschul SF, Gish W, Miller W, et al. Basic local alignment search tool. J Mol Biol 1990 ; 215 : 403–410. [CrossRef] [PubMed]
  5. Liang P, Pardee AB. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 1992 ; 257 : 967–971. [CrossRef] [PubMed]
  6. Van Gelder RN, von Zastrow ME, Yool A, et al. Amplified RNA synthesized from limited quantities of heterogeneous cDNA. Proc Natl Acad Sci USA 1990 ; 87 : 1663–1667. [CrossRef]
  7. Emmert-Buck MR, Bonner RF, Smith PD, et al. Laser capture microdissection. Science 1996 ; 274 : 998–1001. [CrossRef] [PubMed]
  8. Schena M, Shalon D, Davis RW, et al. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995 ; 270 : 467–470. [CrossRef] [PubMed]
  9. DeRisi J, Penland L, Brown PO, et al. Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet 1996 ; 14 : 457–460. [CrossRef] [PubMed]
  10. Lockhart DJ, Dong H, Byrne MC, et al. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol 1996 ; 14 : 1675–1680. [CrossRef] [PubMed]
  11. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA. 1998 ; 95 : 14863–14868. [CrossRef]
  12. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B 1995 ; 57 : 289–300.
  13. Ihaka R, Gentleman RR. A language for data analysis and graphics. J Comput Graph Stat 1996 ; 5 : 299–314. [CrossRef]
  14. Keating P, Cambrosio A. Too many numbers: microarrays in clinical cancer research. Stud Hist Philos Biol Biomed Sci 2012 ; 43 : 37–51. [CrossRef] [PubMed]
  15. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001 ; 98 : 5116–5121. [CrossRef]
  16. Brazma A, Hingamp P, Quackenbush J, et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 2001 ; 29 : 365–371. [CrossRef] [PubMed]
  17. Ashburner M, Ball CA, Blake JA, et al. Gene ontology: tool for the unification of biology. The gene ontology consortium. Nat Genet 2000 ; 25 : 25–29. [CrossRef] [PubMed]
  18. Golub TR, Slonim DK, Tamayo P, et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999 ; 286 : 531–537. [CrossRef] [PubMed]
  19. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000 ; 403 : 503–511. [CrossRef] [PubMed]
  20. Perou CM, Jeffrey SS, van de Rijn M, et al. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc Natl Acad Sci USA 1999 ; 96 : 9212–9217. [CrossRef]
  21. Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature 2000 ; 406 : 747–752. [CrossRef] [PubMed]
  22. Sorlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001 ; 98 : 10869–10874. [CrossRef]
  23. van ‘t Veer LJ, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002 ; 415 : 530–536. [CrossRef] [PubMed]
  24. Paik S, Shak S, Tang G, et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 2004 ; 351 : 2817–2826. [CrossRef] [PubMed]
  25. Kohli-Laven N, Bourret P, Keating P, Cambrosio A. Cancer clinical trials in the era of genomic signatures: biomedical innovation, clinical utility, and regulatory-scientific hybrids. Soc Stud Sci 2011 ; 41 : 487–513. [CrossRef] [PubMed]
  26. Simon R, Radmacher MD, Dobbin K, McShane LM. Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification. J Natl Cancer Inst 2003 ; 95 : 14–18. [CrossRef] [PubMed]
  27. Keating P, Cambrosio A. Cancer on trial: oncology as a new style of practice. Chicago : University of Chicago Press, 2012 : 424 p.
  28. Rogers S, Cambrosio A. Making a new technology work: the standardization and regulation of microarrays. Yale J Biol Med 2007 ; 80 : 165–178. [PubMed]
  29. Borreson Dale AL. Bench, bedside, bytes and back: a virtuous cycle of knowledge. 2011. http://www.ecancermedicalscience.com/tv/video-by-category.asp?play=891&cid=2&scid=101&q=
  30. Irizzary RA, Hobbs B, Collin F, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003 ; 4 : 249–264. [CrossRef] [PubMed]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.